Clinical trials
Withdrawn Multiple Myeloma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Arkansas | 7 |
| Dana-Farber Cancer Institute | 3 |
| National Cancer Institute (NCI) | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Wake Forest University Health Sciences | 3 |
| Fred Hutchinson Cancer Center | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Mayo Clinic | 2 |
| University of California, San Francisco | 2 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 64 |
| Recurrence | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma | 6 |
| Neoplasms, Plasma Cell | 6 |
| Burkitt Lymphoma | 5 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.